Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2011

Open Access 01-12-2011 | Review

Through the looking glass: understanding non-inferiority

Authors: Jennifer Schumi, Janet T Wittes

Published in: Trials | Issue 1/2011

Login to get access

Abstract

Non-inferiority trials test whether a new product is not unacceptably worse than a product already in use. This paper introduces concepts related to non-inferiority, and discusses the regulatory views of both the European Medicines Agency and the United States Food and Drug Administration.
Appendix
Available only for authorised users
Literature
1.
Temple R, Ellenberg SS: Placebo-controlled trials and active-control trials in the evaluation of new treatments; Part 1: Ethical and scientific issues. Annals of Internal Medicine. 2000, 133: 455-463.CrossRefPubMed
2.
Ellenberg SS, Temple R: Placebo-controlled trials and active-control trials in the evaluation of new treatments; Part 2: Practical issues and specific cases. Annals of Internal Medicine. 2000, 133: 464-470.CrossRefPubMed
3.
Wittes J: Active-control trials: a linguistic problem. International Chinese Stat Assoc Bulletin. 2001, 39-40.
4.
Wiens BL, Zhao W: The role of intention to treat in analysis of noninferiority studies. Clin Trials. 2007, 4: 286-291. 10.1177/1740774507079443.CrossRefPubMed
5.
EMA Committee for Proprietary Medicinal Products (CPMP): Points to Consider on Switching between Superiority and Non-inferiority London. 2000
6.
United States Food and Drug Administration: Guidance for Industry Non-Inferiority Clinical Trials. 2010
7.
Rothmann M, Li N, Chen G: Design and analysis of non-inferiority mortality trials in oncology. Stat Med. 2003, 22: 239-264.CrossRefPubMed
8.
Rothmann MD, Tsou HH: On non-inferiority analysis based on delta-method confidence intervals. J Biopharm Stat. 2003, 13: 565-583. 10.1081/BIP-120022775.CrossRefPubMed
9.
EMA Committee for Medicinal Products for Human Use (CHMP): Guideline on the Choice of the Non-inferiority Margin London. 2005
10.
Snappin S, Jiang Q: Controlling the type 1 error rate in non-inferiority trials. Stat Med. 2008, 27: 371-381. 10.1002/sim.3072.CrossRef
11.
Snappin S, Jiang Q: Preservation of effect and the regulatory approval of new treatments on the basis of non-inferiority trials. Stat Med. 2008, 27: 382-391. 10.1002/sim.3073.CrossRef
12.
Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959, 22: 719-748.PubMed
13.
Yusuf S, Collins R: Why do we need some large, simple randomized trials?. Stat Med. 1984, 3: 409-420. 10.1002/sim.4780030421.CrossRefPubMed
14.
DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials. 1986, 7: 177-188. 10.1016/0197-2456(86)90046-2.CrossRefPubMed
15.
Petitti DB: Meta-analysis, Decision Analysis, and Cost-effectiveness Analysis: Methods for Quantitative Synthesis in Medicine. 2000, Oxford: Oxford University Press, 306 pp
16.
Teo KK, Yusuf S: Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomized trials. BMJ. 1991, 303: 1499-1503. 10.1136/bmj.303.6816.1499.CrossRefPubMedPubMedCentral
17.
Fleming TR: Current issues in non-inferiority trials. Stat Med. 2008, 27: 317-332. 10.1002/sim.2855.CrossRefPubMed
18.
Metadata
Title
Through the looking glass: understanding non-inferiority
Authors
Jennifer Schumi
Janet T Wittes
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Trials / Issue 1/2011
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-12-106

Other articles of this Issue 1/2011

Trials 1/2011 Go to the issue

Research

A Single-Blind randomized controlled trial to evaluate the effect of extended counseling on uptake of pre-antiretroviral care in eastern uganda

Research

Pilot randomized trial of therapeutic hypothermia with serial cranial ultrasound and 18-22 month follow-up for neonatal encephalopathy in a low resource hospital setting in uganda: study protocol

Study protocol

Preventative tele-health supported services for early stage chronic obstructive pulmonary disease: a protocol for a pragmatic randomized controlled trial pilot

Study protocol

The Active for Life Year 5 (AFLY5) school based cluster randomised controlled trial: study protocol for a randomized controlled trial

Study protocol

Efficacy of electroacupuncture at Zhongliao point (BL33) for mild and moderate benign prostatic hyperplasia: study protocol for a randomized controlled trial

Study protocol

The STRATOB study: design of a randomized controlled clinical trial of Cognitive Behavioral Therapy and Brief Strategic Therapy with telecare in patients with obesity and binge-eating disorder referred to residential nutritional rehabilitation